Hemics Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
Hemics General Information
Description
Developer of medical imaging and inflammation assessment devices intended for rheumatoid arthritis monitoring and clinical evaluation purposes. The company develops non-invasive optical imaging systems based on patented inflammation detection technology, disease activity monitoring support, and objective visualization tools for inflammatory joint conditions, enabling rheumatologists, healthcare providers, and medical facilities to assess inflammatory status more consistently and support treatment decision-making for patients with rheumatoid arthritis.
Contact Information
Website
www.hemics.comCorporate Office
- Kanaaldijk 29
- 5683 CR Best
- Netherlands
Corporate Office
- Kanaaldijk 29
- 5683 CR Best
- Netherlands
Hemics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Nov-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 09-Jan-2015 | Completed | Startup | |||
| 2. Grant | 08-Jan-2014 | $68.5K | Completed | Startup | ||
| 1. Early Stage VC | 20-Sep-2011 | Completed | Startup |
Hemics Patents
Hemics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140132428-A1 | Aeronautical safety device | Active | 11-Feb-2011 | ||
| US-9000951-B2 | Aeronautical safety device | Inactive | 11-Feb-2011 | ||
| EP-2642910-A1 | Device and method for determining a disease activity | Active | 26-Nov-2010 | ||
| EP-2642910-B1 | Device and method for determining a disease activity | Active | 26-Nov-2010 | ||
| US-20130310697-A1 | Device and method for determining a disease activity | Active | 26-Nov-2010 | A61B5/4528 |
Hemics Signals
Hemics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | ||
| DFZ Participaties | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Point One Innovation Fund | Venture Capital | Minority | ||
| Thuja Capital Management | Venture Capital | Minority |
Hemics FAQs
-
When was Hemics founded?
Hemics was founded in 2011.
-
Where is Hemics headquartered?
Hemics is headquartered in Best, Netherlands.
-
What is the size of Hemics?
Hemics has 3 total employees.
-
What industry is Hemics in?
Hemics’s primary industry is Diagnostic Equipment.
-
Is Hemics a private or public company?
Hemics is a Private company.
-
What is Hemics’s current revenue?
The current revenue for Hemics is .
-
Who are Hemics’s investors?
Brabantse Ontwikkelings Maatschappij, DFZ Participaties, Horizon 2020, Point One Innovation Fund, and Thuja Capital Management have invested in Hemics.
-
When was Hemics acquired?
Hemics was acquired on 01-Nov-2018.
-
Who acquired Hemics?
Hemics was acquired by Demcon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process